Skip to content
Search

Latest Stories

Wales launches electronic prescribing service (EPS)

Wales launches electronic prescribing service (EPS)

Wellington Road Pharmacy becomes the first community pharmacy in the country to use the EPS

Wales launched the new electronic prescribing service (EPS) last week, with the country’s first electronic prescription sent and dispensed on 17 November.


The new service allows prescriptions to be sent digitally to a patient’s nominated pharmacy, thus eliminating the need for paper forms.

It is part of a wider plan to introduce digital medicines and e-prescribing in all hospitals and primary care in the country.

Wellington Road Pharmacy and Lakeside Medical Centre in Rhyl became the first community pharmacy and GP practice to use the EPS, which is expected to be rolled out across Wales in January 2024.

Speaking at the EPS launch in Rhyl, Eluned Morgan, minister for health and social services, said: “We are at the start of an exciting digital transformation that will completely change the way prescriptions are managed in primary care, streamlining a process that has not altered significantly in decades.”

Charlotte Smith, lead pharmacist at Wellington Road Pharmacy, spoke about the benefits of using EPS and said “it’s more convenient, secure and free.”

“It will allow us to track where the prescriptions are, whether they’re at the GP practice or the pharmacy,” she told the Pharmaceutical Journal.

Andrew Evans, chief pharmaceutical officer for Wales, expressed that “Digital innovation is key to improving the prescription service for patients and our hard-working pharmacists and GPs.”

In September 2021, the Welsh government first announced its plan to implement electronic prescribing across all healthcare settings within three to five years.

At the beginning of this year (January 2023), Morgan said that the first electronic prescriptions were expected to be sent from GP practices to dispensing pharmacies “in summer or early autumn 2023”.

Wales is the third country to introduce EPS, after England and Scotland, which both launched the service in 2009.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less